Alvotech (ALVO) Current Assets (2020 - 2026)
Alvotech's (ALVO) quarterly Current Assets came in at $456.0 million in Q1 2026, down 0.63% YoY from $458.9 million in Q1 2025, and down 20.56% on a QoQ basis from $574.0 million in Q4 2025.
Alvotech (ALVO) Current Assets (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Current Assets data on file, last reported at $456.0 million in Q1 2026.
- Quarterly Current Assets fell 0.63% year-over-year to $456.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $456.0 million (down 0.63% YoY) and the FY2025 annual result came in at $574.0 million, up 26.15% from the prior year.
- Current Assets retreated to $456.0 million in Q1 2026, from $574.0 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $574.0 million in Q4 2025 to a low of $194.8 million in Q4 2023.
- A 5-year average of $361.7 million and a median of $362.5 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets fell 15.56% — and 2024, when it jumped 133.53%.
- Tracing ALVO's Current Assets over 5 years: stood at $230.7 million in 2022, then slipped by 15.56% to $194.8 million in 2023, then jumped by 133.53% to $455.0 million in 2024, then advanced by 26.15% to $574.0 million in 2025, then retreated by 20.56% to $456.0 million in 2026.
- The last three Current Assets figures came in at $456.0 million (Q1 2026), $574.0 million (Q4 2025), and $455.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | 455.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 455.98 Mn |
| Dec 31, 2025 | 574.02 Mn |
| Sep 30, 2025 | 455.02 Mn |
| Jun 30, 2025 | 509.46 Mn |
| Mar 31, 2025 | 458.87 Mn |
| Dec 31, 2024 | 455.02 Mn |
| Sep 30, 2024 | 432.61 Mn |
| Jun 30, 2024 | 285.19 Mn |
| Mar 31, 2024 | 292.30 Mn |
| Dec 31, 2023 | 194.84 Mn |
| Jun 30, 2023 | 211.91 Mn |
| Mar 31, 2023 | 269.14 Mn |
| Dec 31, 2022 | 230.74 Mn |
| Jun 30, 2022 | 238.66 Mn |
| Dec 31, 2021 | 119.82 Mn |
| Dec 31, 2020 | 86.16 Mn |